Oxorhenium(V) complexes of the general formula [ReOCl2(PPh3)(L)] (2a-c) and [ReOCl(L)2] (3a-c) with L being monoanionic, bidentate phenolate-pyrazole ligands 1a-c that bear substituents with various electronic features on the phenol ring (1a Br, 1b NO2, 1c OMe) were prepared. The compounds are stable toward moisture and air, allowing them to be handled in a normal lab atmosphere. All complexes were fully characterized by spectroscopic means and, in the case of 2b, 2c, 3b, and 3c, also by single-crystal X-ray diffraction analyses. Electrochemical investigations by cyclic voltammetry of complexes 3a-c showed a shift to more positive potentials for the Re(V)/Re(VI) redox couple in the order of 3b > 3a > 3c (R = NO2 > Br > OMe), reflecting the higher electrophilic character of the Re atom caused by the ligands 1a-c. Complexes 2a-c and 3a-c display excellent catalytic activity in the epoxidation of cyclooctene, where all six complexes give quantitative conversions to the epoxide within 3 h if tert-butylhydroperoxide (TBHP) is employed as oxidant. Moreover, they represent rare examples of oxorhenium(V) catalysts capable of using the green oxidant hydrogen peroxide, leading to high yields up to 74%. Also, green solvents such as diethylcarbonate can be used successfully in epoxidation reactions, albeit resulting in lower yields (up to 30%).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/ic501794z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Necrosis-Inducing High-Valent Oxo-Rhenium(V) Complexes with Potent Antitumor Activity: Synthesis, Aquation Chemistry, Cisplatin Cross-Resistance Profile, and Mechanism of Action.
Inorg Chem
December 2023
Laboratory of Medicinal Chemistry and Cell Biology, Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Navy Nagar, 400005 Mumbai, India.
Chemotherapy with the cytotoxic platinum (Pt) drugs cisplatin, carboplatin, and oxaliplatin is the mainstay of anticancer therapy in the clinic. The antitumor activity of Pt drugs originates from their ability to induce apoptosis via covalent adduct formation with nuclear DNA. While the phenomenal clinical success is highly encouraging, resistance and adverse toxic side effects limit the wider applicability of Pt drugs.
View Article and Find Full Text PDFDrug combination study of novel oxorhenium(V) complexes.
J Inorg Biochem
June 2022
Department of General and Inorganic Chemistry, University of Belgrade-Faculty of Chemistry, Studentski trg 12-16, 11000 Belgrade, Serbia. Electronic address:
Three Re(V) complexes of structural formulas [ReOClL(PPh)], where L is pyridine-2-carboxylic acid (C1), 3-methyl-pyridine-2-carboxylic acid (C2) and 6-methyl-pyridine-2-carboxylic acid (C3) were synthesized and characterized using NMR, IR spectroscopy and mass spectrometry. Crystal structures of all three complexes have been additionally confirmed by X-ray analysis. The biological activity has been investigated in the panel of tumor cell lines A549, PANC-1, MDA-MB-231, MCF-7, LS-174, EAhy.
View Article and Find Full Text PDFOxorhenium(V) and Oxotechnetium(V) Complexes of NS Tetradentate Ligands with a Styrylpyridyl Functional Group: Toward Imaging Agents to Assist in the Diagnosis of Alzheimer's Disease.
Inorg Chem
September 2021
School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia.
Alzheimer's disease (AD) is associated with the presence of amyloid plaques in the brain mainly comprised of aggregated forms of amyloid-β (Aβ). Molecules radiolabeled with technetium-99m that cross the blood-brain barrier (BBB) and selectively bind to Aβ plaques have the potential to assist in the diagnosis of AD using single-photon emission computed tomography imaging. In this work, three new tetradentate ligands of pyridyl, amide, amine and thiol donors, featuring a styrylpyridyl group that is known to interact with amyloid plaques, were prepared.
View Article and Find Full Text PDFEffect of Fluorination on the Structure and Anti- Activity of Oxorhenium(V) Complexes with ,,-Tridentate Thiosemicarbazones and Benzoylthioureas. Synthesis and Structures of Technetium(V) Analogues.
Inorg Chem
August 2019
Institute of Chemistry and Biochemistry , Freie Universität Berlin, Fabeckstrasse 34-36 , D-14195 Berlin , Germany.
A series of 16 "3 + 2" mixed-ligand complexes of the general composition [ReO(L1)(L2)] (HL1a-HL1d = tridentate thiosemicarbazones having a phenyl group with 4-H, 4-F, 3,5-di-F, and 4-CF substituents; HL2a-HL2d = bidentate ,-diethyl-'-benzoylthioureas with 4-H, 4-F, 3,5-di-F, and 4-CF substituents at the benzoyl groups) have been synthesized and characterized by spectroscopic methods and X-ray diffraction. Irrespective of the individual fluorine substitution, the complexes are stable and possess the same general structure. Some systematic electronic effects of the fluorine-substitution patterns of the ligands have been found on the C NMR chemical shifts of the N-C═N carbon atoms of the {L1} and the C═O carbon atoms of the {L2} ligands.
View Article and Find Full Text PDFLigand Design for Isomer-Selective Oxorhenium(V) Complex Synthesis.
Inorg Chem
February 2017
Department of Civil and Environmental Engineering, Colorado School of Mines, Golden, Colorado 80401, United States.
Recently, N,N-trans Re(O)(L)X (L = monoanionic N-O chelates; X = Cl or Br prior to being replaced by solvents or alkoxides) complexes have been found to be superior to the corresponding N,N-cis isomers in the catalytic reduction of perchlorate via oxygen atom transfer. However, reported methods for Re(O)(L)X synthesis often yield only the N,N-cis complex or a mixture of trans and cis isomers. This study reports a geometry-inspired ligand design rationale that selectively yields N,N-trans Re(O)(L)Cl complexes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!